Q4 2015 Holdings
Filed 2016-02-16 | 82 holdings | $128.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ardelyx Inc(ARDX) | COM | 039697107 | $26.8M | 1,481,075 | 20.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $23.1M | 245,000 | 18.0% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $17.5M | 647,944 | 13.6% |
| Cellectis SA(CLLS) | SPONSORED ADS | 15117K103 | $14.6M | 469,145 | 11.3% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $13.1M | 569,130 | 10.2% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $12.4M | 450,000 | 9.6% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $11.1M | 1,080,000 | 8.7% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $7.7M | 371,023 | 6.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $1.1M | 61,500 | 0.9% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $302.0K | 25,000 | 0.2% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $55.6K | 700,000 | 0.0% |
| Dyax Corp | COM | 26746E103 | $52.7K | 1,400,000 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $45.0K | 1,685,719 | 0.0% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $35.5K | 400,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $34.2K | 603,900 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $30.8K | 1,960,000 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $25.7K | 500,000 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $25.0K | 757,475 | 0.0% |
| Quotient LTD | SHS | G73268107 | $24.3K | 1,519,100 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $18.4K | 315,000 | 0.0% |
| Sorrento Therapeutics Inc(SRNE) | COM NEW | 83587F202 | $18.3K | 2,095,334 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $17.9K | 265,386 | 0.0% |
| China Biologic Products Inc | COM | 16938C106 | $15.9K | 111,500 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $15.7K | 495,356 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $15.5K | 500,000 | 0.0% |
| Tesaro Inc | COM | 881569107 | $15.2K | 291,250 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $13.9K | 575,000 | 0.0% |
| Novavax Inc | COM | 670002104 | $13.4K | 1,600,000 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $12.9K | 765,156 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $12.5K | 153,000 | 0.0% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $12.3K | 109,500 | 0.0% |
| Rockwell Medical Inc | COM | 774374102 | $11.3K | 1,105,000 | 0.0% |
| Vitae Pharmaceuticals Inc | COM | 92847N103 | $11.3K | 623,409 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $11.0K | 753,388 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $9.8K | 200,000 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $8.8K | 250,000 | 0.0% |
| Lipocine Inc | COM | 53630X104 | $8.6K | 666,666 | 0.0% |
| Advaxis Inc | COM NEW | 007624208 | $8.0K | 800,000 | 0.0% |
| Pfenex Inc | COM | 717071104 | $7.7K | 624,900 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $7.1K | 1,559,000 | 0.0% |
| Recro Pharma Inc | COM | 75629F109 | $7.0K | 780,000 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $7.0K | 1,145,043 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $6.4K | 335,068 | 0.0% |
| Wave Life Sciences PTE LTD(WVE) | SHS | Y95308105 | $6.3K | 392,079 | 0.0% |
| Bellicum Pharmaceuticals Inc | COM | 079481107 | $6.1K | 300,000 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $5.9K | 170,000 | 0.0% |
| Achillion Pharmaceuticals in(ACHNEUR) | COM | 00448Q201 | $5.4K | 500,000 | 0.0% |
| Intec Pharma LTD | SHS | M53644106 | $4.3K | 800,000 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $4.3K | 266,250 | 0.0% |
| Kite Pharma Inc | COM | 49803L109 | $4.2K | 68,800 | 0.0% |